Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation

Bone Marrow Transplantation volume 27, pages 341–343 (2001)Cite this article

Abstract

Four patients with AL amyloidosis underwent high-dose chemotherapy and autologous stem cell transplantation at our institutions. Here, we report the clinical courses and outcomes in these patients. Two patients with multi-organ amyloid deposits including cardiac involvement died within 12 days after high-dose chemotherapy. However, in the other two patients, one of whom was suffering from amyloid-related cardiac failure, a significant improvement of organ function was achieved. Bone Marrow Transplantation (2001) 27, 341–343.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kyle RA, Gertz MA . Primary systemic amyloidosis: clinical and laboratory features in 474 cases Semin Hematol 1995 32: 45–59

    CAS  Google Scholar 

  2. Kyle RA, Gertz MA, Greipp PR et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisolone, and melphalan, prednisolone and colchicine New Engl J Med 1997 336: 1202–1207

    Article  CAS  Google Scholar 

  3. Comenzo RL, Sanchorawala V, Fisher C et al. Intermediate melphalan and blood stem cells mobilized with sequential GM + G-CSF or G-CSF alone to treat AL (amyloid light chain) amyloidosis Br J Haematol 1999 104: 553–559

    Article  CAS  Google Scholar 

  4. Comenzo RL, Falk RH, Sanchorawala V et al. Treating AL amyloidosis with dose-intensive melphalan: outcomes in 102 patients Blood 1998 92: (Suppl. 1) 324a (Abstr. 1328)

    Google Scholar 

  5. Moreau P, Leblond V, Bourquelot P et al. Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients Br J Haematol 1998 101: 766–769

    Article  CAS  Google Scholar 

  6. Fattori R, Rocchi G, Celleti F et al. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy Am Heart J 1998 136: 824–830

    Article  CAS  Google Scholar 

  7. Apperley JF, Gilmore J, Haynes A et al. Autografting for AL amyloidosis: recommendations for patient selection Bone Marrow Transplant 1998 21: (Suppl. 1) S212 (Abstr. 744)

    Google Scholar 

  8. Moreau P . Autologous stem cell transplantation for AL amyloidosis: a standard therapy? Leukemia 1999 13: 1929–1931

    Article  CAS  Google Scholar 

  9. Comenzo RL . High-dose therapy for the treatment of primary systemic amyloidosis. In: Schechter GP, Hoffman R, Schier SL, Bajus JL (eds) Hematology 1999 American Society of Hematology Education Program Book 1999 pp 347–357

  10. Saba N, Tsang R, Sutton DM et al. High treatment related mortality in cardiac amyloid patients undergoing autologous stem cell transplant Bone Marrow Transplant 1999 24: 853–855

    Article  CAS  Google Scholar 

  11. Desikan KR, Dhodapkar, Hough A et al. Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation Leuk Lymphoma 1997 27: 315–319

    Article  CAS  Google Scholar 

  12. Moreau P, Milpied N, de Faucal P et al. High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement Blood 1996 87: 3063–3064

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology, Charité University Hospital, Campus Berlin-Buch, Oncology and Tumour Immunology, Campus Virchow-Klinikum, Humboldt University of Berlin, Germany

    G Reich, B Dörken & G Maschmeyer

  2. Department of Haematology and Oncology, Charité University Hospital, Humboldt University of Berlin, Germany

    Th Held & W Siegert

  3. Department of Nephrology (3), Charité University Hospital, Humboldt University of Berlin, Germany

    D Kampf

Authors
  1. G Reich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Th Held
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Siegert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Kampf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B Dörken
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Maschmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reich, G., Held, T., Siegert, W. et al. Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 27, 341–343 (2001). https://doi.org/10.1038/sj.bmt.1702766

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702766

Keywords

This article is cited by

Search

Advanced search

Quick links